Shuyun Zhao

Shuyun Zhao


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2024 in Aging
Verified
Journal Article
Open access
PDF file
CHChangyudong Huang
Changyudong Huang
YZYiqiong Zhang
Yiqiong Zhang
YXYongjie Xu
Yongjie Xu
SWSijia Wei
Sijia Wei
TYTingting Yang
Tingting Yang
WPWei Pan
Wei Pan
As one of the most common liver diseases, nonalcoholic fatty liver disease (NAFLD) affects almost one-quarter of the world’s population. Although the prevalence of NAFLD is continuously rising, effective medical treatments are still inadequate. Radix Polygoni Multiflori (RPM) is a traditional Chinese herbal medicine. As a processed product of RPM, prepared Radix Polygoni Multiflori (PRPM) has been reported to have antioxidant and anti-inflammatory effects. This study investigated whether PRPM treatment could significantly improve NAFLD. We used recent literature, the Herb database and the SwissADME database to isolate the active compounds of PRPM. The OMIM, DisGeNET and GeneCards databases were used to isolate NAFLD-related target genes, and GO functional enrichment and KEGG pathway enrichment analyses were conducted. Moreover, PRPM treatment in NAFLD model mice was evaluated. The results indicate that the target genes are mainly enriched in the AMPK and de novo lipogenesis signaling pathways and that PRPM treatment improves NAFLD disease in model mice. Here, we found the potential benefits of PRPM against NAFLD and demonstrated in vivo and in vitro that PRPM and its ingredient emodin downregulate phosphorylated P38/P38, phosphorylated ERK1/2 and genes related to de novo adipogenesis signaling pathways and reduce lipid droplet accumulation. In conclusion, our findings revealed a novel therapeutic role for PRPM in the treatment of NAFLD and metabolic inflammation.

10 April 2026 in iScience
Verified
Journal Article
Open access
YLYongyan Lu
Yongyan Lu
GWGuangli Wang
Guangli Wang
XQXueyu Qin
Xueyu Qin
GHGuanyou Huang
Guanyou Huang
SZShuyun Zhao
Shuyun Zhao
HLHeng Luo
Heng Luo
Endometritis is a common inflammatory disorder of the female reproductive tract caused by microbial infection or immune dysregulation that impairs endometrial function and reproductive outcomes. Growing evidence indicates that programmed cell death (PCD), particularly pyroptosis, plays a pivotal role in the pathophysiology of endometritis. Pyroptosis links cell death to inflammatory signaling through inflammasome activation and gasdermin (GSDM)-mediated membrane perforation. The canonical NLRP3-caspase-1-GSDMD axis, the noncanonical caspase-4/5/11-GSDMD pathway, and caspase-3-GSDME-dependent pyroptosis-like death all have been implicated in amplifying endometrial inflammation. Experimental and clinical studies demonstrate the upregulation of NLRP3, caspase-1, and GSDMD in affected endometrial tissues, supporting their pathological relevance. Upstream mechanisms, including the high-mobility group box 1 (HMGB1)-TLR4 axis, PI3K-AKT signaling, and microRNA (miRNA)-mediated modulation, further regulate the pyroptotic response. These insights highlight therapeutic opportunities, including pharmacological inhibitors, miRNA-based interventions, and antioxidant strategies. Nevertheless, most evidence derives from preclinical studies, and translational validation in patients remains limited. This review presents an integrated molecular framework and candidate therapeutic targets to support diagnostic stratification and precision interventions that optimize reproductive outcomes.

29 January 2026 in Advanced Science
Verified
Journal Article
Open access
ZHZhu Hu
Zhu Hu
YYYuanyuan Yu
Yuanyuan Yu
GHGuanyou Huang
Guanyou Huang
JLJinnan Li
Jinnan Li
CYChao Yang
Chao Yang
TZTuo Zhang
Tuo Zhang
Poor ovarian response (POR) constitutes a notable clinical challenge within the domain of assisted reproductive technology, primarily attributable to the lack of reliable biomarkers for precise diagnosis and treatment. This study reveals significantly reduced levels of insulin‐like growth factor 1 (IGF‐1) in the serum, follicular fluid (FF), and granulosa cells (GCs) of patients with POR in comparison to those exhibiting a normal ovarian response (NOR). Notably, FF IGF‐1 concentrations demonstrated significant positive correlations with crucial IVF outcomes, including the numbers of metaphase II (MII) oocytes, 2‐pronuclear zygotes, and high‐quality embryos. To establish causality, we employed complementary in vivo models: systemic insulin‐like growth factor binding protein acid labile subunit ( Igfals ) knockout mice and granulosa cell specific IGF‐1 receptor ( Igf‐1r ) knockout mice. These models collectively demonstrated that disruption of the IGF‐1 signaling axis impairs follicle‐stimulating hormone (FSH) responsiveness and arrests follicular development at the secondary stage, thereby recapitulating the core POR phenotype. Building on these mechanistic insights, we developed novel clinical prediction tools based on FF IGF‐1: a POR risk model [Area under the curve (AUC) = 0.914] and a pregnancy outcome nomogram (AUC = 0.893), both of which significantly outperform traditional ovarian reserve parameters (such as anti‐Müllerian hormone and antral follicle count). Decision curve analysis (DCA) further validated a substantial clinical net benefit. This study aids clinicians in the early identification of patients with POR and provides a theoretical foundation for timely intervention and adjustment of treatment strategies.